Literature DB >> 6290902

beta-Adrenoceptor ligand binding and supersensitivity to isoprenaline of ventricular muscle after chronic reserpine pretreatment.

M H Hawthorn, K J Broadley.   

Abstract

1. Isolated papillary muscles from guinea-pig hearts were paced at a constant frequency and isometric contractions reported. 2. Guinea-pigs were either untreated or pretreated with reserpine. Three pretreatment schedules were used; a) 0.5 mg kg-1 i.p. at 24 h, b) 5.0 mg kg-1 at 72 h and 3.0 mg kg-1 at 48 and 24 h, or c) 0.1 mg kg-1 daily for 7 days. 3. Cumulative concentration-response curves for the isoprenaline-induced increases in tension were obtained. The geometric mean EC50 values after the 3 and 7 day reserpine pretreatment schedules were significantly (P less than 0.05) less than for untreated guinea-pigs indicating a supersensitivity. 4. EC50 values for the positive inotropic responses to histamine and calcium in papillary muscles from reserpine-pretreated guinea-pigs did not differ significantly (P less than 0.05) from those from untreated animals. This suggests that the supersensitivity to isoprenaline is beta-adrenoceptor specific. 5. Membrane fractions were prepared from the ventricles of the untreated and reserpine-pretreated guinea-pigs from which papillary muscles had been removed. Binding of [3H]-dihydroalprenolol ([3H]-DHA) to beta-adrenoceptors of these membranes was determined. Equilibrium dissociation constants (KD) and total numbers of binding sites (Bmax) were determined by Scatchard analysis of the saturation curves for [3H]-DHA binding. 6. There was no increase in affinity (fall in KD value) or change in the total number of binding sites associated with reserpine-induced supersensitivity. The equilibrium inhibition constant (Ki) for the displacement of [3H]-DHA binding by isoprenaline was also identical in membranes from untreated and reserpine-pretreated animals. Thus reserpine-induced supersensitivity to isoprenaline does not appear to involve a change in affinity for the beta-adrenoceptor or in receptor numbers as determined by [3H]-DHA binding.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6290902     DOI: 10.1007/bf00510135

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  22 in total

1.  The development of supersensitivity to norepinephrine after pretreatment with reserpine.

Authors:  W W FLEMING; U TRENDELENBURG
Journal:  J Pharmacol Exp Ther       Date:  1961-07       Impact factor: 4.030

Review 2.  Reserpine-induced supersensitivity to the cardiac effects of agonists.

Authors:  K D Meisheri; T E Tenner; J H McNeill
Journal:  Life Sci       Date:  1979-02-05       Impact factor: 5.037

3.  A relatively nonspecific supersensitivity in aortic strips resulting from pretreatment with reserpine.

Authors:  P M Hudgins; W W Fleming
Journal:  J Pharmacol Exp Ther       Date:  1966-07       Impact factor: 4.030

4.  The influence of reserpine on the calcium-induced responses of spontaneously beating isolated rabbit atria.

Authors:  H A Jurevics; O Carrier
Journal:  J Pharmacol Exp Ther       Date:  1973-01       Impact factor: 4.030

5.  Sensitivity changes in the dog heart to norepinephrine, calcium and aminophyline resulting from pretreatment with reserpine.

Authors:  D P Westfall; W W Fleming
Journal:  J Pharmacol Exp Ther       Date:  1968-01       Impact factor: 4.030

6.  Reserpine induced cardiac supersensitivity.

Authors:  T E Tenner
Journal:  Proc West Pharmacol Soc       Date:  1979

7.  Analysis of reserpine-induced supersensitivity in aortic strips of rabbits.

Authors:  J Taylor; R D Green
Journal:  J Pharmacol Exp Ther       Date:  1971-04       Impact factor: 4.030

8.  Chronic effects of 6-hydroxydopamine and reserpine on myocardial adenylate cyclase.

Authors:  T H Chiu
Journal:  Eur J Pharmacol       Date:  1978-12-01       Impact factor: 4.432

9.  The role of calcium in supersensitivity to the inotropic effects of norepinephrine.

Authors:  T E Tenner; J H McNeill; O Carrier
Journal:  Eur J Pharmacol       Date:  1978-08-15       Impact factor: 4.432

10.  Selective reserpine-induced supersensitivity of the positive inotropic and chronotropic responses to isoprenaline and salbutamol in guinea-pig isolated atria.

Authors:  K J Broadley; P Lumley
Journal:  Br J Pharmacol       Date:  1977-01       Impact factor: 8.739

View more
  7 in total

1.  Targeted disruption of the mouse beta1-adrenergic receptor gene: developmental and cardiovascular effects.

Authors:  D K Rohrer; K H Desai; J R Jasper; M E Stevens; D P Regula; G S Barsh; D Bernstein; B K Kobilka
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

2.  Alterations in beta-adrenoceptor number and catecholamine content of chick atria after reversible sympathetic denervation with 6-hydroxydopamine.

Authors:  K Williams; P G Strange; T Bennett
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-07       Impact factor: 3.000

3.  Affinities of full agonists for cardiac beta-adrenoceptors calculated by use of in vitro desensitization.

Authors:  M L Herepath; K J Broadley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-06       Impact factor: 3.000

4.  Local cardiac effects of substance P: roles of acetylcholine and noradrenaline.

Authors:  H Chiao; R W Caldwell
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

5.  Temporal changes in myocardial adrenergic regulation with the progression to pump dysfunction after chronic beta-adrenoreceptor activation in rats.

Authors:  Oleg E Osadchii; Angela J Woodiwiss; Dawn Deftereos; Gavin R Norton
Journal:  Pflugers Arch       Date:  2007-06-09       Impact factor: 3.657

6.  Regulation of beta-adrenoceptors in the guinea-pig sinoatrial node.

Authors:  F D Russell; A R Kompa; P Molenaar; R J Summers
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-05       Impact factor: 3.000

7.  Cardiac alpha- and beta-adrenoceptor sensitivity and binding characteristics after chronic reserpine pretreatment.

Authors:  R G Chess-Williams; P F Grassby; K J Broadley; D J Sheridan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-12       Impact factor: 3.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.